Medications for Breast Carcinoma

2 results
  • trazimera - trastuzumab - qyyp

    (Trastuzumab-Qyyp)
    Pfizer Laboratories Div Pfizer Inc
    Trazimera treats HER2-overexpressing breast cancer in adults, including adjuvant node-positive or high-risk node-negative disease, first-line metastatic breast cancer (with paclitaxel), and single-agent use after prior chemotherapy. Also indicated for HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma with cisplatin and capecitabine or 5-fluorouracil.
  • zoladex - goserelin implant

    (Goserelin)
    Tersera Therapeutics Llc
    Zoladex treats locally confined and advanced prostate carcinoma, endometriosis, and advanced breast cancer in pre- and perimenopausal women. Also used as an endometrial-thinning agent before ablation for dysfunctional uterine bleeding.